Hervé Tilly

[AbbVie France @AbbVieFrance]

Aujourd'hui c'est la journée mondiale du lymphome, mais le(s) connaissez-vous vraiment ?🤔
🎥 En ce #MoisDesCancersDuSang, Dr Lepretre, hématologue au @CentreBecquerel, décrypte pour vous le, ou plutôt les, lymphome(s) dans cet épisode de la Minute Hémato👇

[Hervé Tilly @TillyHerve]

@RaclureTwo 😀

[Vincent Camus @VincentCamus76]

Very honored to have received one of the two Bertrand Coiffier 2023 Awards. Thank you very much to @EliLymphoma , @LysaLymphoma and the International Jury for awarding this prize allowing me to realize a research mobility in Prof. Davide Rossi's lab at the @IOR_Bellinzona

[ELI @EliLymphoma]

The winners of the Bertrand Coiffier 2023 award, Jean Lemoine and Vincent Camus, presented their projects at the LYSA meeting @LysaLymphoma

[Marek Trneny @MarekTrnenyDr]

⁦@EliLymphoma⁩ meeting is just starting in Dubrovnik

[ELI @EliLymphoma]

Next week, hybrid ELI workshop : “Genomics of lymphoma: from basic to clinical use”

[Hervé Tilly @TillyHerve]

@Jessica_Okosun @QMBCI @QMUL Félicitations !

[Hervé Tilly @TillyHerve]

@Kersten_MJ @graham74GC And French authority rejected the possibility of reimbursement! ��

[Hervé Tilly @TillyHerve]

@DrAnasYounes Congrats!

[Hervé Tilly @TillyHerve]

@graham74GC Have a speedy recovery

[Tanya Skrypets @TSkrypets]

Additionally, Also my colleagues from national Cancer Institute (Kiev) did auto SCT for lymphoma patient in a bombshell!!! You cannot plan transplant based on a bombing timetable😡 @TheEBMT @EHA_Hematology @ASH_hematology @StefanoLuminari @AnnaSureda5 @Mohty_EBMT

[Ingrid Glimelius @glimelius]

Conclusion, patients do quite well and have limited extra days in hospital despite R-CHOP

[Hervé Tilly @TillyHerve]

@ClarkHenegan @f2harrell @gilles_salles @ChrisRFlowersMD Thank you for this careful reading. You should refer to version 7 of the protocol (and not V1, both in the appendix of the NEJM) on p 112. And also the updated sample size in statistical analysis plan V3. Best.

[NEJM @NEJM]

Up to 40% of patients receiving the standard R-CHOP regimen for diffuse large B-cell lymphoma have refractory disease or relapse. A modified regimen might improve outcomes. New research findings are summarized in a short video. https://t.co/WZ0xuPhotS

[CentreHenriBecquerel @CentreBecquerel]

En 2022, construisons ensemble le futur de la lutte contre le cancer. Le @CentreBecquerel vous adresse ses meilleurs vœux pour cette nouvelle année 2022 !

[Hervé Tilly @TillyHerve]

@sloan_kettering @gilles_salles Félicitations Gilles!

[Hervé Tilly @TillyHerve]

@MarekTrnenyDr Hopefully you will explain it to us soon 🥴

[Hervé Tilly @TillyHerve]

First day stamp from Europe to UK. A giant leap for mankind ?

[Martin Hutchings @DocHutchings]

Final results of the dose-escalation part of the phase 1-2 study of #Epcoritamab in r/r B-cell #lymphoma now online in #Lancet. We @rigshospitalet are proud and priviliged to be part of this study. #lymsm https://t.co/6j9nu652ph

[Institut Curie @institut_curie]

#Nomination | « Par ses valeurs et son histoire, l’Institut Curie porte une profonde dimension humaniste que je m’engage à poursuivre. »

A compter du 1er septembre, le Pr Steven Le Gouill 🧑‍⚕️ prend la direction de l’Ensemble Hospitalier de l’Institut Curie. ⬇️